Lista de obras - J Xie - Dominio Público Uruguay

Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.

artículo científico publicado en 2017

Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.

artículo científico publicado en 2017

Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients

artículo científico publicado en 2014

Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections.

artículo científico publicado en 2014

Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections

artículo científico publicado en 2015

Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis

artículo científico publicado en 2017

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis

artículo científico publicado en 2014

Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease

artículo científico publicado en 2017

Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital

artículo científico publicado en 2015

Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation

artículo científico publicado en 2013

Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

artículo científico publicado en 2016

Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections

artículo científico publicado en 2015

Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations.

artículo científico publicado en 2016

Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis

artículo científico publicado en 2018

Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections

artículo científico publicado en 2017

Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration

scientific article published on 04 July 2019

Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.

artículo científico publicado en 2018

Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.

artículo científico publicado en 2014

Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method

artículo científico publicado en 2014

Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.

artículo científico publicado en 2016

The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in Chinese

artículo científico publicado en 2014

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients

artículo científico publicado en 2014

Lista de obras de J Xie

Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.

Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.

Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients

Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections.

Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections

Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis

Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease

Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital

Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation

Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections

Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations.

Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis

Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections

Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration

Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.

Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.

Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method

Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.

The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in Chinese

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients